Tekla Healthcare Investors (NYSE:HQH) Director Thomas M. Kent bought 1,100 shares of the stock in a transaction on Thursday, January 25th. The shares were acquired at an average cost of $24.19 per share, with a total value of $26,609.00. Following the acquisition, the director now directly owns 1,100 shares in the company, valued at approximately $26,609. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Tekla Healthcare Investors (NYSE:HQH) traded up $0.12 on Monday, reaching $24.74. 67,185 shares of the company’s stock were exchanged, compared to its average volume of 172,989. Tekla Healthcare Investors has a 12-month low of $21.75 and a 12-month high of $26.37. The firm has a market cap of $982.04, a price-to-earnings ratio of 8.40 and a beta of 1.73.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in HQH. Tower Research Capital LLC TRC acquired a new stake in Tekla Healthcare Investors during the 2nd quarter worth $112,000. Acropolis Investment Management LLC acquired a new stake in Tekla Healthcare Investors during the 4th quarter worth $130,000. Laurel Wealth Advisors Inc. grew its holdings in Tekla Healthcare Investors by 0.6% during the 2nd quarter. Laurel Wealth Advisors Inc. now owns 9,581 shares of the financial services provider’s stock worth $240,000 after acquiring an additional 54 shares during the period. Advisor Group Inc. grew its holdings in Tekla Healthcare Investors by 0.3% during the 2nd quarter. Advisor Group Inc. now owns 10,518 shares of the financial services provider’s stock worth $264,000 after acquiring an additional 30 shares during the period. Finally, Moloney Securities Asset Management LLC acquired a new stake in Tekla Healthcare Investors during the 3rd quarter worth $367,000. 16.82% of the stock is owned by hedge funds and other institutional investors.
About Tekla Healthcare Investors
Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. It seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets.
Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.